Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$57.98 - $96.6 $834,912 - $1.39 Million
-14,400 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$71.56 - $121.23 $135,248 - $229,124
-1,890 Reduced 11.6%
14,400 $1.1 Million
Q4 2020

Feb 02, 2021

SELL
$47.41 - $115.03 $14,222 - $34,509
-300 Reduced 1.81%
16,290 $1.44 Million
Q3 2020

Nov 05, 2020

BUY
$43.0 - $84.01 $36,335 - $70,988
845 Added 5.37%
16,590 $1.23 Million
Q2 2020

Aug 12, 2020

SELL
$51.3 - $75.21 $545,678 - $800,008
-10,637 Reduced 40.32%
15,745 $1.15 Million
Q1 2020

May 12, 2020

BUY
$31.51 - $73.75 $217,576 - $509,243
6,905 Added 35.45%
26,382 $1.48 Million
Q4 2019

Jan 27, 2020

BUY
$17.25 - $49.51 $335,978 - $964,306
19,477 New
19,477 $743,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $189M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.